OMER Q3 2020 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M-12.5% YoY

Gross Profit

$26M98.5% margin

Operating Income

-$25M-97.4% margin

Net Income

-$38M-147.3% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

+93.0%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$227M

Total Liabilities

$314M

Stockholders' Equity

-$87M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$30M	-12.5%
Gross Profit	$26M	$30M	-13.1%
Operating Income	-$25M	-$11M	-129.1%
Net Income	-$38M	-$16M	-133.6%